Biologic Immunosuppression

Biologic Immunosuppression is a class of immunosuppressive therapy that selectively modulates specific components of the immune system through biologically derived agents, such as monoclonal antibodies or recombinant proteins, to achieve targeted immune suppression.

106

Publications

5.2K

Citations

776

Authors

241

Institutions

Publications per year

2017–2026

14

Variants

Biological Immunosuppression

Authors

776

  1. AD
    Allan D. Kirk

    Emory University, United States

    5 publications · 207 citations

    5

    h-index

  2. IK
    Ismat Khatri

    University of Toronto, Canada

    2 publications · 37 citations

    2

    h-index

  3. SK
    Sayeed K. Malek

    Brigham and Women's Hospital, United States

    2 publications · 69 citations

    2

    h-index

  4. SS
    Stuart S. Kaufman

    Georgetown University, United States

    2 publications · 148 citations

    2

    h-index

  5. JJ
    John J. Fung

    University of Pittsburgh, United States

    2 publications · 251 citations

    2

    h-index

1–5 of 776

Venues

  1. Transplantation

    27 publications · 1.3K citations

    20

    h-index

  2. PubMed

    Repository · 8 publications · 216 citations

    8

    h-index

  3. American Journal of Transplantation

    5 publications · 219 citations

    5

    h-index

  4. Transplantation Proceedings

    3 publications · 42 citations

    3

    h-index

  5. Nephrology Dialysis Transplantation

    NDT · 3 publications · 137 citations

    3

    h-index

1–5